SUMMARY Forty-seven cases of Charcot-Marie-Tooth peripheral neuropathy were seen in 18 families within a defined area, with a disease prevalence of 1 in 16 400. Maximum motor nerve conduction velocity (MNCV) measurement divided off two types of neuropathy and >40 ms-1), but did not distinguish clinically affected from normal in families whose probands had median nerve MNCV >40 ms-1. In the neuronal type of neuropathy (MNCV >40 ms-1) two genotypes were seen, autosomal dominant (ADN) and autosomal recessive (ARN) 
The term Charcot-Marie-Tooth disease is used here to describe those inherited, chronic, mixed but predominantly motor, peripheral neuropathies whose clinical features include peroneal and distal leg muscle weakness and wasting, foot drop, and often foot deformity of the pes cavus type. This definition is derived from analysis of the original papers of Charcot and Marie' and Tooth2 and is in accord with that given by de Recondo.3 The eponym is not used synonymously with peroneal muscular atrophy, since the variously inherited peripheral neuropathies of Charcot-Marie-Tooth disease are regarded as one pathological cause of the clinical syndrome of peroneal muscular atrophy.4
This paper describes an investigation of an unselected group of patients with established Charcot-Marie-Tooth disease. The family study was designed to ascertain all cases in a defined geographical area, to establish the degree of genetic heterogeneity, and particularly to correlate phenotypic features with the genotypes identified as an aid to genetic counselling. All subjects were seen within one year and were personally examined.
Probands living in the geographical area under study were ascertained from the records of the University Department of Human Genetics, Edinburgh, and from the local orthopaedic, neurological, and paediatric clinics. All probands and secondary cases found in their families had clear 
